Crossmark

Targeting STING with covalent small-molecule inhibitors

Crossref DOI link: https://doi.org/10.1038/s41586-018-0287-8

Published Online: 2018-07-04

Published Print: 2018-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Haag, Simone M.

Gulen, Muhammet F.

Reymond, Luc

Gibelin, Antoine

Abrami, Laurence

Decout, Alexiane

Heymann, Michael

van der Goot, F. Gisou

Turcatti, Gerardo

Behrendt, Rayk

Ablasser, Andrea
License Information

Text and Data Mining valid from 2018-07-01
More Information

Article History

Received: 8 September 2017

Accepted: 24 May 2018

First Online: 4 July 2018

Competing interests

: A.A. is a consultant to IFM Therapeutics, LLC. A.A., S.M.H., L.R. and the EPFL have filed provisional patent applications related to STING inhibitors. All other authors declare no competing interests.